UK cuts self-isolation for COVID-19 cases to 7 days
“We want to reduce the disruption from COVID-19 to people’s everyday lives,” said Secretary of State for Health and Social Care Sajid Javid
Company
Pfizer Inc
NYSE:PFE
Pfizer Inc is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1.
293 stories · page 5 of 15
Pfizer's new oral treatment effective against Omicron says pharma
Boris Johnson warns his cabinet that a "huge spike" of the omicron variant is coming.
Pfizer's acquisition of Arena "shows big pharma's interest in cannabinoid medicines"
Arena was CBDX's fourth-largest holdings at the end of November, at 11.8%.
Pfizer and Moderna are best COVID-19 booster jabs, new study suggests
Britain decided to use only the Pfizer and Moderna jabs for its Covid-19 booster
Pfizer antiviral pill study shown to reduce risk of death from COVID-19 by 89%
The US pharmaceuticals company said it plans to submit the study data to the US Food and Drug Administration for Emergency Use Authorisation as soon as possible
COVID-19: Pfizer vaccine protection could drop to 20% after 5 months, study shows
The findings suggest that a large proportion of the vaccinated population could lose protection against infection in the coming months
COVID-19: Pfizer vaccine protection drops to 47% after six months
The reduction in the vaccine’s effectiveness against COVID-19 infection was due to its waning over time and not because of Delta or other variants
Pfizer and BioNTech to seek approval to vaccinate children after Covid study
Results were comparable to a previous Pfizer-BioNTech study in people 16 to 25 years of age immunised with three times larger doses
Coronavirus: Vaccine immunity starts waning after six months, study finds
Health experts are calling for the rollout of COVID-19 vaccine booster doses to keep protection levels high
US stocks finish higher on strong durable goods data
On the day, the Dow rose 39 points to 35,405, while the S&P 500 added 10 points at 4,496 and the tech-heavy Nasdaq edged up 22 points to 15,042.
Archive
The Pay Zone - Oil price, UJO/Egdon/Europa, Hunting, President, Prospex. And finally…
Oil price So, we’ve had a shakeout and yesterday saw a decent recovery, along with today’s rise Brent is nearly 8% off the lows which can be attributed to a number of factors. I would divide by country, firstly the USA where sentiment that
Coronavirus: US issues full approval for Pfizer vaccine
The approval is likely to trigger institutions, such as school and governmental bodies, to require vaccine certifications
Britain orders more Pfizer Covid-19 jabs as booster programme nears
Antibody tests will be freely available from tomorrow to people testing positive after a PCR test
US to recommend third COVID-19 vaccine dose as booster
An official announcement is expected as early as this week
US stocks finish strongly, add to record highs to end the week
The S&P 500 and Dow set intraday highs at Friday's close
Pfizer accused of abusing market position to overcharge NHS with 1,600% price hikes
Prices were lifted between 780% and 1,600% for the epilepsy drug than had previously been charged, with its UK distributor then selling the capsules at prices up to 2,600% higher than had been paid before
Pfizer asks for Covid-19 booster shot permission as UK infection rate jumps again
“The Pfizer vaccine is highly active against the Delta variant”
Pfizer treatment cuts severe Covid-19 deaths by 40% in trial
Xeljanz or tofacitinib is a new kind of drug known as a JAK inhibitor
Archive
Wall Street coasts to a comfortable close
The bulk of Monday's gains were achieved at or near the opening bell
Pharma companies to produce 11.4bn COVID-19 vaccine doses by year-end, says Goldman Sachs
Pfizer, AstraZeneca and Moderna will pump out a big chunk of the total